Visit the IMC COVID-19 Resource Centre
IMC Logo
  • About
  • Medicines
  • Innovation
  • Ethics
  • Resources
  • News
  • FR
  • About
  • Medicines
  • Innovation
  • Ethics
  • Resources
  • News
  • FR
MEMBER LOGIN

© 2015 IMC. All Rights Reserved

November 25, 2020

Statement: COVID-19 Vaccine Manufacturing Capacity

Read More
January 13, 2021

MEET THE EXPERTS: JOE FARAGO

Joe Farago is Executive Director, Private Payers and Investment at Innovative Medicines Canada (IMC). Joe leads IMC’s efforts to take a more proactive, research-based approach to ensuring tomorrow’s workforce has […]

January 13, 2021

New IMC report shows impact of chronic disease and increased claims on private drug plans

Growth in chronic disease and increased drug claims […]

December 30, 2020

Delaying implementation of PMPRB’s Regulations an opportunity to protect patient access to medicines and vaccines

We support Health Canada’s decision to delay […]

December 29, 2020

IMC says there is still time for the federal government to put Canadian patients first by delaying the January 1, 2021 implementation of PMPRB’s Regulations and Guidelines

Ottawa, December 29, 2020 – Innovative Medicines Canada (IMC) issued the following statement today regarding the looming implementation of the Patented Medicines Prices Review Board’s (PMPRB’s) Final Regulations and Guidelines, […]

December 21, 2020

Still time for federal government to act to protect patient access to new medicines and vaccines before January 1, 2021 implementation of new PMPRB Regulations and Guidelines

Ottawa, December 21, 2020—Innovative Medicines Canada (IMC) issued the following statement today warning of the impact the Patented Medicines Prices Review Board’s (PMPRB’s) Final Regulations and Guidelines will have on […]

Press Releases

January 13, 2021

New IMC report shows impact of chronic disease and increased claims on private drug plans

More Press Releases

Blog

January 13, 2021

MEET THE EXPERTS: JOE FARAGO

More Blog

Health Research Foundation

Canada’s Health Research Foundation invests in health innovation in Canada.

Visit Site

Contact Us

Membership enquiries
Wilma Deen:
wdeen@imc-mnc.ca
613-236-0455, ext. 207

General enquiries
613-236-0455

Media enquiries
Sarah Dion-Marquis:
sdmarquis@imc-mnc.ca
613-769-6510

info@imc-mnc.ca

55 Metcalfe Street, Suite 1220
Ottawa, Ontario K1P 6L5

Member Login

Lost Password?

  • Terms and Conditions
  • Privacy Policy
  • Competition Guidelines
  • Accessible Service Plan
  • Competition Guidelines Regarding Meetings

© 2020 INNOVATIVE MEDICINES CANADA. All Rights Reserved

MEMBER OF

ifpma